Bio-Works Technologies AB (publ) (NGM:BIOWKS)

Bio-Works Technologies AB Statistics

Total Valuation

NGM:BIOWKS has a market cap or net worth of SEK 386.04 million. The enterprise value is 344.79 million.

Market Cap	386.04M
Enterprise Value	344.79M

Important Dates

The last earnings date was Wednesday, May 13, 2026.

Earnings Date	May 13, 2026
Ex-Dividend Date	n/a

Share Statistics

NGM:BIOWKS has 100.01 million shares outstanding. The number of shares has increased by 43.33% in one year.

Current Share Class	100.01M
Shares Outstanding	100.01M
Shares Change (YoY)	+43.33%
Shares Change (QoQ)	+10.90%
Owned by Insiders (%)	27.97%
Owned by Institutions (%)	8.57%
Float	44.84M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.64
PB Ratio	7.02
P/TBV Ratio	7.02
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-132.92
EV / Sales	4.14
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-35.90

Financial Position

The company has a current ratio of 4.43

Current Ratio	4.43
Quick Ratio	3.27
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-6,110.00

Financial Efficiency

Return on equity (ROE) is -5.67% and return on invested capital (ROIC) is -8.35%.

Return on Equity (ROE)	-5.67%
Return on Assets (ROA)	-6.05%
Return on Invested Capital (ROIC)	-8.35%
Return on Capital Employed (ROCE)	-11.11%
Weighted Average Cost of Capital (WACC)	7.09%
Revenue Per Employee	2.68M
Profits Per Employee	-83,677
Employee Count	31
Asset Turnover	1.32
Inventory Turnover	1.50

Taxes

Income Tax	-1.90M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +167.13% in the last 52 weeks. The beta is 0.52, so NGM:BIOWKS's price volatility has been lower than the market average.

Beta (5Y)	0.52
52-Week Price Change	+167.13%
50-Day Moving Average	3.29
200-Day Moving Average	2.82
Relative Strength Index (RSI)	68.28
Average Volume (20 Days)	71,774

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NGM:BIOWKS had revenue of SEK 83.23 million and -2.59 million in losses. Loss per share was -0.03.

Revenue	83.23M
Gross Profit	62.52M
Operating Income	-6.11M
Pretax Income	-4.50M
Net Income	-2.59M
EBITDA	-5.60M
EBIT	-6.11M
Loss Per Share	-0.03

Balance Sheet

The company has 41.26 million in cash and n/a in debt, with a net cash position of 41.26 million or 0.41 per share.

Cash & Cash Equivalents	41.26M
Total Debt	n/a
Net Cash	41.26M
Net Cash Per Share	0.41
Equity (Book Value)	55.02M
Book Value Per Share	0.59
Working Capital	53.33M

Cash Flow

In the last 12 months, operating cash flow was -9.10 million and capital expenditures -507,000, giving a free cash flow of -9.60 million.

Operating Cash Flow	-9.10M
Capital Expenditures	-507,000
Depreciation & Amortization	508,000
Net Borrowing	n/a
Free Cash Flow	-9.60M
FCF Per Share	-0.10

Margins

Gross margin is 75.12%, with operating and profit margins of -7.34% and -3.12%.

Gross Margin	75.12%
Operating Margin	-7.34%
Pretax Margin	-5.40%
Profit Margin	-3.12%
EBITDA Margin	-6.73%
EBIT Margin	-7.34%
FCF Margin	n/a

Dividends & Yields

NGM:BIOWKS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-43.33%
Shareholder Yield	-43.33%
Earnings Yield	-0.67%
FCF Yield	-2.49%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1